Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (141-150 of 439) with videos related to

Pageof 44
Sort By:
BMC Bioinformatics|July 27, 2017
Quantification of tumour evolution and heterogeneity via Bayesian epiallele detectionJames E Barrett, Andrew Feber, Javier Herrero, et al.
Immunological Reviews|April 18, 2018
The function and dysfunction of memory CD8<sup>+</sup> T cells in tumor immunityJames L Reading, Felipe Gálvez-Cancino, Charles Swanton, et al.
Oncotarget|June 29, 2011
A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variablesDavid Endesfelder, Nicholas McGranahan, Nicolai J Birkbak, et al.
European Urology|May 20, 2014
Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implicationsMarco Gerlinger, James W Catto, Torben F Orntoft, et al.
Royal Society Open Science|July 18, 2024
An agent-based modelling framework to study growth mechanisms in <i>EGFR-L858R</i> mutant cell alveolar type II cellsHelena Coggan, Clare E Weeden, Philip Pearce, et al.
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
BJU International|August 23, 2014
Multidisciplinary urological engagement in translational renal cancer researchGrant D Stewart, David J Harrison, Charles Swanton, et al.
Lancet (London, England)|September 7, 2016
Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseCrispin T Hiley, John Le Quesne, George Santis, et al.
The Lancet. Oncology|June 9, 2017
Evolving adoptive cellular therapies in urological malignanciesYien Ning Sophia Wong, Kroopa Joshi, Martin Pule, et al.
Nature Cancer|February 5, 2022
Securing the future of the clinician-scientistKaren Noble, Joanna Owens, Fabrice André, et al.
Pageof 44

Showing results (141-150 of 439) with videos related to

Sort By:
Pageof 44
BMC Bioinformatics|July 27, 2017
Quantification of tumour evolution and heterogeneity via Bayesian epiallele detectionJames E Barrett, Andrew Feber, Javier Herrero, et al.
Immunological Reviews|April 18, 2018
The function and dysfunction of memory CD8<sup>+</sup> T cells in tumor immunityJames L Reading, Felipe Gálvez-Cancino, Charles Swanton, et al.
Oncotarget|June 29, 2011
A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variablesDavid Endesfelder, Nicholas McGranahan, Nicolai J Birkbak, et al.
European Urology|May 20, 2014
Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implicationsMarco Gerlinger, James W Catto, Torben F Orntoft, et al.
Royal Society Open Science|July 18, 2024
An agent-based modelling framework to study growth mechanisms in <i>EGFR-L858R</i> mutant cell alveolar type II cellsHelena Coggan, Clare E Weeden, Philip Pearce, et al.
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
BJU International|August 23, 2014
Multidisciplinary urological engagement in translational renal cancer researchGrant D Stewart, David J Harrison, Charles Swanton, et al.
Lancet (London, England)|September 7, 2016
Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseCrispin T Hiley, John Le Quesne, George Santis, et al.
The Lancet. Oncology|June 9, 2017
Evolving adoptive cellular therapies in urological malignanciesYien Ning Sophia Wong, Kroopa Joshi, Martin Pule, et al.
Nature Cancer|February 5, 2022
Securing the future of the clinician-scientistKaren Noble, Joanna Owens, Fabrice André, et al.
Pageof 44